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Autism Spectrum Disorder (ASD) is the collective term for neurodevelopmental disorders
characterized by qualitative impairments in social interaction, communication, and a
restricted range of activities and interests. Many countries, including Australia, have
reported a dramatic increase in the number of diagnoses over the past three decades,
with current prevalence of ASD at 1 in every 110 individuals (∼1%). The potential role
for an immune-mediated mechanism in ASD has been implicated by several studies, and
some evidence suggests a potential link between prenatal infection-driven inflammation
and subsequent development of ASD. Furthermore, a modest number of contemporary
studies have reported a markedly increased prevalence of ASD in children born preterm,
who are at highest risk of exposure to perinatal inflammation. However, the mechanisms
that underpin the susceptibility to infection-driven inflammation during pregnancy and risk
of preterm birth, and how these intersect with the subsequent development of ASD in
the offspring, is not understood. This review aims to summarize and discuss the potential
mechanisms and evidence for the role of prenatal infection on the central nervous system,
and how it may increase the susceptibility for ASD pathogenesis in children born preterm.
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INTRODUCTION
Autism Spectrum Disorder (ASD) is the collective term for neu-
rodevelopmental disorders characterized by qualitative impair-
ments in social interaction, communication, and a restricted
range of activities and interests (Association, 2000). Autistic
Disorder, Pervasive Developmental Disorder—Not Otherwise
Specified (PDD-NOS) and Asperger’s Disorder differ with regard
to the quality and quantity of symptoms, but are thought to
share a similar genetic liability (Freitag, 2007). ASD is a grow-
ing public health concern. Many countries, including Australia
(Williams et al., 2008b), have reported a dramatic increase in the
number of ASD diagnoses over the past three decades from less
than 1 in 1000 individuals with a form of ASD (Chakrabarti and
Fombonne, 2001; Wing and Potter, 2002) to 1 in every 110 (∼1%)
(CDC, 2006). While some assessment factors may be respon-
sible for part of the increase, including changes in diagnostic
criteria, different assessment instruments and increased autism
awareness (Matson and Kozlowski, 2011), several environmental
and epigenetic factors have also been implicated. In particular, a
range of perinatal exposures are associated with ASD, including
heavy metal and pesticide exposure, stress, smoking, and use of
anti-depressant medication during pregnancy and certain foods
(Dietert et al., 2011). These same factors are also associated with
preterm birth, and it is important to note that a number of con-
temporary studies have reported an increased prevalence of ASD
in preterm populations (Kolevzon et al., 2007).
PREMATURITY AND ASD
Ameta-analysis of seven retrospective epidemiologic studies, rep-
resenting five different geographic locations concluded that the
following factors were associated with an increased risk of ASD;
low birth weight, reduced gestational age at birth, birth asphyxia,
and advanced maternal age (>35 years), along with a maternal
place of birth outside Europe/North America (Kolevzon et al.,
2007). A further five epidemiological studies published after 2007
found similar associations (Schendel and Bhasin, 2008; Williams
et al., 2008a; Buchmayer et al., 2009; Schieve et al., 2011; Guinchat
et al., 2012; Lampi et al., 2012; Movsas and Paneth, 2012), with
the exception of Schieve et al. (2011), who found that prematu-
rity did not account for a significant proportion of the increase
in ASD prevalence. Yet this study addressed the predictive factors
associated with the recent increase in ASD prevalence, rather than
ASD diagnosis per se. A caveat to these findings, however, there
was an over-representation of children with severe forms of ASD,
indicating that these studies may suffer from self-selection bias.
In terms of gestational age, there is evidence that the qualita-
tive and quantitative nature of ASD symptomatology may differ
across gestational age bands. Movsas and Paneth (2012) identified
that for infants born less than 34 weeks, the largest impairments
were within the domains of social cognition, social communica-
tion and autistic mannerisms. For children born between 34 and
36 weeks, all domains were equally affected (Movsas and Paneth,
2012).
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FIGURE 1 | Potential interactions between infection-led inflammation and neurodevelopment in Autism Spectrum Disorders.
Several prospective studies of ASD in preterm population
(based on parental questionnaire-based data) have demon-
strated a comparatively elevated risk for ASD in preterm chil-
dren, although the incidence of ASD varied widely between
studies (19.4–41%) (Sargent, 1993; Zenclussen et al., 2007;
Limperopoulos et al., 2008; Hack et al., 2009; Kuban et al., 2009;
Moore et al., 2012). The populations examined all consisted of
extremely preterm children (<28 weeks) or of very low birth
weight (<1500 g), and the children were assessed for ASD at less
than three years of age. Results should be interpreted with caution
however, as the formal diagnosis of ASD is reached in signifi-
cantly fewer individuals than implicated by positive questionnaire
screening (Romero et al., 2003), and the incidence of positive
screening for ASD is significantly higher for populations with
other significant neurological, cognitive, and sensory sequelae
(Coe and Lubach, 2005; Williams et al., 2008a).
Two prospective studies have included information on chil-
dren formally diagnosed with ASD (Romero et al., 2006; Meyer
et al., 2007). The first recruited 219 children (age 11 years)
born before 26 weeks gestation in 1995 in the UK and Ireland
and compared rates of ASD diagnosis to 152 children born
at term (Meyer et al., 2007). Overall 8% of preterm children
were assigned a diagnosis of ASD compared to none in the
term group. Notably, 16% of preterm and 3% of term children
screened positive based on a questionnaire alone, again emphasiz-
ing the need for caution when interpreting questionnaire-based
screening data. Of those with a formal diagnosis, 13 had autis-
tic disorder and three with PDD-NOS, representing a prevalence
between 4 and 12 times higher than the general population
(Meyer et al., 2007). The second study by Pinto-Martin and col-
leagues, recruited 623 infants of moderately low birth weight
(<2000 g) born between 1984 and 1987 in NJ, USA (Romero
et al., 2006). At age 21, the overall prevalence rate of ASD for the
cohort was 5%, whereas questionnaire screening identified 18.8%
as positive.
In summary, these retrospective and prospective epidemiolog-
ical studies provide some evidence that prematurity, measured
either as gestational age or birth weight, increases the risk and
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alters the symptomology of ASD. Yet it remains clear that fur-
ther large prospective cohort studies of children born preterm
are required to confirm the exact incidence and identify other
potentially modifying risk factors. Such research also does not
resolve how prematurity could mechanistically lead to the devel-
opment of ASD. The answer to this question may lie with
one or more of the many recognized antecedents of preterm
birth, in particular, exposure to maternal/fetal infection and
inflammation.
THE MATERNAL AND FETAL INFLAMMATORY RESPONSES
TO INFECTION
During pregnancy, maternal immunity is associated systemi-
cally with enhanced suppressor responses and greater suscep-
tibility of the mother to a range of infections, particularly
with viral and intracellular pathogens (Chheda et al., 1996).
On an anatomical level, a range of active tolerance mecha-
nisms, including the induction of regulatory T cells, hormones
and anti-inflammatory cytokines, ensure that fetal rejection
does not occur (Jones et al., 1996). Maternal infections can,
and do result in inflammatory responses (Gotsch et al., 2007;
Agrawal and Hirsch, 2012; Burd et al., 2012), and these are inti-
mately related to the onset of spontaneous labor and preterm
birth (Burd et al., 2009; Brown, 2011; Meyer et al., 2011).
Additionally, ascending intrauterine bacterial infections are com-
mon among mothers who deliver preterm [up to 40% (Brown,
2012)], and this is associated with placental inflammation as
well as fetal inflammatory cytokine responses (Pararas et al.,
2006).
Research suggests that exposure of the developing fetus, either
directly to infection and inflammation, or indirectly via maternal
inflammation, can impact on development of the CNS and there-
fore possibly contribute to ASD. This evidence will be discussed in
turn. However, a causal relationship between infection-induced
inflammation and ASD has not been formally established and
important mechanistic questions remain.
WHAT IS THE EVIDENCE FOR A ROLE OF PRENATAL
INFECTION IN THE DEVELOPMENT OF ASD?
Maternal prenatal infections have been linked to neurodevel-
opmental and neurological disorders, including cerebral palsy
(Goldenberg et al., 2000, 2008), schizophrenia and ASD (Lamont
and Sawant, 2005). An association between maternal infection
and schizophrenia is supported by both human studies and ani-
mal pregnancymodels (Chaiworapongsa et al., 2002). Hypotheses
aimed at explaining this relationship have focused on the action
of inflammatory cytokines on the developing fetal brain, or
the induction of deleterious maternal autoimmune responses, as
likely routes to altered neurodevelopment (Lamont and Sawant,
2005). As schizophrenia and ASD share both clinical and biolog-
ical links, research has subsequently turned to evaluate the role
of prenatal infection/inflammation and ASD (Gavilanes et al.,
2009).
BACTERIAL INFECTIONS
Maternal bacterial infection during pregnancy is intrinsi-
cally linked with preterm delivery (Hatfield et al., 2011).
Chorioamnionitis (inflammation of the chorionic disc, mater-
nal and/or fetal membranes, cord and/or amniotic fluid) is
associated with approximately 25–40% of all preterm births
(Wu, 2002; Wharton et al., 2004; Shatrov et al., 2010), and
can result in elevated inflammatory markers in the amniotic
fluid, cord and newborn peripheral blood and cerebrospinal
fluid (Stephens et al., 2012). Alterations in brain morphol-
ogy following prenatal exposure to chorioamnionitis have been
reported, and include a decreased number of neurons in
the cortex, hippocampus and substantia nigra (Samara et al.,
2008) as well as diffuse global changes in cortical thickness
(Johnson and Marlow, 2009). Exposure to clinical and histo-
logical chorioamnionitis has been associated with white matter
injury and worse neurological outcomes, including cerebral palsy
(Schendel et al., 2009; Johnson et al., 2010). Importantly, the
presence of a fetal inflammatory response appears more pre-
dictive of brain injury than maternal inflammation (Redline
et al., 1998, 2000; Yoon et al., 2000, 2001; Pinto-Martin et al.,
2011).
Few studies have addressed the potential association between
maternal bacterial infections and ASD. In 2010, Atladottir et al.
(2010a,b) reported an association between maternal bacterial
infection during the second trimester and the diagnosis of ASD
in the child (adjusted hazard ration of 1.42). They were not
able to discern the causative pathogens associated with this
effect, but noted that the most common infections were uro-
genital (∼75%) and suggested that the observed association
could be due to “transplacental passage of maternally pro-
duced cytokines or antibodies in response to the infection”
(p. 1429). Limperopoulos et al. (2008) observed that for 91
very low birth weight infants, chorioamnionitis was signifi-
cantly associated with an abnormal autism screening score,
with an OR of 9.669 (95% CI 3.302–28.310). In contrast
to the above studies, Abdallah et al. found no significant
associations between prenatal maternal infections (outpa-
tient and hospital admissions) and the development of ASD
(Abdallah et al., 2012).
Studies using animal models support the findings in humans
and have identified an increased risk of several behaviors
characteristic of ASD in the offspring of lipopolysaccharide
(LPS)-activated mothers (Malkova et al., 2012). Such deficits
include communication (ultrasonic vocalizations) (Malkova,
2010), social interaction (Smith et al., 2007), elevated anxiety and
inhibition deficits (Patterson, 2009; Meyer and Feldon, 2010).
VIRAL INFECTIONS
There is less evidence that viral infections can increase the risk
preterm birth in comparison to bacterial infections (Srinivas
et al., 2006). Nevertheless, maternal viral infection is often asso-
ciated with an increase in the incidence of psychiatric disorders
with a neurodevelopmental origin, particularly schizophrenia
(Brown and Patterson, 2011). Maternal influenza infection dur-
ing the first trimester has also been associated with an increased
risk of ASDs in the offspring in a study by Atladottir et al.
(2010a). This finding is supported by laboratory evidence,
whereby an influenza infection induced the gene expression
of various proinflammatory and chemo-attractive cytokines in
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cultured human fetal membrane cells (Uchide et al., 2005).
Furthermore, respiratory infection with the human influenza
virus at mid-gestation in animal models results in behav-
ioral and pharmacological abnormalities (Patterson, 2002; Shi
et al., 2003), along with widespread reduction in gray mat-
ter volume in the cortex and reduced white matter volume
in the parietal cortex (Short et al., 2010). The Atladottir
and colleagues study was also subject to bias, as they were
based on infections requiring admission to hospital, and did
not include subclinical infections, or those treated by general
practitioner.
Other viruses for which a potential association with ASD
and related disorders have been suggested include congeni-
tal rubella (Freedman et al., 1970; Chess, 1971, 1977; Stubbs,
1995), herpes, cytomegalovirus (Stern and Tucker, 1973; Stubbs,
1978; Markowitz, 1983; Ivarsson et al., 1990; Ciaranello and
Ciaranello, 1995; Yamashita et al., 2003; Sweeten et al., 2004),
varicella (Ciaranello and Ciaranello, 1995), mumps (Ciaranello
and Ciaranello, 1995), polyomavirus (Lintas et al., 2010) and
enterovirus (Sadeharju et al., 2003; Johnson et al., 2009a).
However, these infections are relatively uncommon and therefore
evidence is restricted to case reports and hypotheses.
MATERNAL AUTOIMMUNE CONDITIONS
Epidemiological studies show that autoimmune diseases
(rheumatoid arthritis, celiac disease, type 1 diabetes) are more
common in mothers of children diagnosed with ASD than
in mothers of children without developmental abnormalities
(Atladottir et al., 2010b; Ashwood et al., 2011a). Animal studies
have demonstrated that injections of rodents or rhesus macaques
during mid-gestation with immunoglobulins isolated from
human mothers of children with ASD results in abnormal
stereotypic behaviors in their offspring (Martin et al., 2008;
Singer et al., 2009). Furthermore, subsets of mothers of chil-
dren with ASD have circulating antibodies which target fetal
brain proteins [as reviewed in Wills et al. (2007)]. Immune
responses to viral infections commonly result in transiently
elevated levels of autoantibodies (Ludewig et al., 2004). It is
therefore conceivable that increased maternal autoimmune
reactivity following viral infections may effect fetal brain devel-
opment, however, further studies are needed to support this
hypothesis.
HOW COULD INFECTION-DRIVEN INFLAMMATION RESULT
IN ASD? EFFECTS ON BRAIN STRUCTURE AND FUNCTION
Intrauterine inflammation is increasingly being recognized as
a key contributor to adverse neurological outcomes in infants
born preterm (Goines et al., 2011). Evidence suggests that infants
and children with ASD exhibit altered immunological status rel-
ative to unaffected children. For example, increased levels of
pro-inflammatory cytokines (IFNγ and IL-6) were observed in
the mid-gestation serum of a mother who went onto deliver
a child with ASD. Further, post-mortem studies of brain and
cerebrospinal fluid of individuals with ASD (8/13 by drown-
ing) have shown an higher degree of inflammation with elevated
cytokine levels and activated microglia and astrocytes com-
pared to control subjects (Morgan et al., 2010; Lintas et al.,
2012). Subjects have ranged in age, indicating that this immune-
activation may begin in early life and be long-lasting (Chez
et al., 2007; Morgan et al., 2010). In addition, peripheral blood
mononuclear cells display altered cytokine responses to stim-
ulation in vitro (Enstrom et al., 2010; Ashwood et al., 2011b;
Goines and Ashwood, 2013) along with inflammation in the gas-
trointestinal tract of a subset of ASD children (Ashwood, 2010;
Buie et al., 2010). This may be especially relevant as proinflam-
matory cytokines (e.g., TNFα, IFNγ, IL-1, IL-6, and IL-8) are
involved in the pathogenesis of preterm infant brain injury, pre-
dominantly white matter damage (Dammann and Leviton, 1997;
Yoon et al., 1997a,b; Patrick and Smith, 2002), and adversely affect
neurodevelopmental processes, including neurogenesis, neuronal
migration, synaptic plasticity, neurotransmission, and myeli-
nation (Zhu et al., 2002; Bauer et al., 2007; Rostene et al.,
2007). Microarray studies have also shown dysregulation of sev-
eral ASD candidate genes known to regulate both brain and
immune system development (Careaga et al., 2010; Lintas et al.,
2012).
It is difficult, however, to attribute infection-related inflam-
mation to aberrant CNS development in individuals with
ASD as ASD is a complex disorder with no common cel-
lular, molecular or systems level unification. Yet the preterm
infant may be at particular risk of neurodevelopmental disabil-
ity, due to a birth occurring during the 2nd trimester (23rd
to 27th weeks) when the brain is particularly vulnerable to
a heightened inflammatory state. Such a time corresponds to
the transformation of oligodendrocytes, migration of neuron
precursors from the germinal plate, and the up-regulation of
excitatory neurotransmitter pathways. Such factors can be linked
to the several neurodevelopmental anomalies noted in ASD
(Shinohe et al., 2006; Hughes, 2007; Bassett and Bullmore,
2009; Wegiel et al., 2010; Deoni et al., 2011; Essa et al.,
2012).
THE ROLE OF MODIFIERS
Despite the emerging evidence for the association between
maternal infection/inflammation and ASD, this relationship
is not universal to all cases of ASD. This is expected, con-
sidering the large heterogeneity of ASD symptomology, and
the number of risk factors currently described. It is there-
fore likely that specific modifying factors influence this asso-
ciation, effecting either protective or injurious susceptibility to
ASD risk. Firstly, the interaction of infection/inflammation and
ASD risk may be modulated by maternal factors during preg-
nancy including smoking, age, mental health and metabolic
disease. And secondly, the clinical presentation among indi-
viduals may be due to gene-gene or gene-environment inter-
action. All modifying factors are unlikely to singularly affect
susceptibility, but are likely to be inter-related and accumula-
tive.
Several maternal factors may increase the likelihood of
preterm birth including smoking during pregnancy (Simpson,
1957; Schwartz et al., 1972; Berkowitz and Papiernik, 1993;
Kaminski, 1997; Shah and Bracken, 2000; Bada et al., 2005;
Kyrklund-Blomberg et al., 2005; Ng and Zelikoff, 2007; McCowan
et al., 2009; Thiriez et al., 2009), age greater than 35 years
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(Cnattingius et al., 1992; Fraser et al., 1995; Gilbert et al., 1999;
Ananth et al., 2001; Jacobsson et al., 2004), metabolic syndrome
(Rey and Couturier, 1994; Catov et al., 2007a,b, 2008, 2010;
Edison et al., 2007; Gilbert et al., 2007; Salihu et al., 2008; Chatzi
et al., 2009; Ehrenberg et al., 2009; Johnson et al., 2009b), poor
nutritional status (Cogswell et al., 2003; Siega-Riz et al., 2006;
Bodnar et al., 2010; Czeizel et al., 2010) and mental health
(Blondel et al., 1990; Oakley et al., 1990; Bryce et al., 1991;
Hedegaard et al., 1996). Several of these factors can also mod-
ulate the level of maternal inflammation during pregnancy. For
example, pregnancy stress results in the section of corticotrophin-
releasing hormone (CRH) from the hypothalamus, and increased
plasma levels of CRH have been linked to preterm labor (Hobel
et al., 1999). While some evidence suggests that such maternal
risk factors can contribute to the development of ASD (Rizzo
et al., 1997; Croen et al., 2002, 2007; Hultman et al., 2002; Glasson
et al., 2004; Beversdorf et al., 2005; Larsson et al., 2005; Lauritsen
et al., 2005; Leonard et al., 2006; Reichenberg et al., 2006; Dionne
et al., 2008; Durkin et al., 2008; Grant and Soles, 2009; Grether
et al., 2009; King et al., 2009; Li et al., 2009a,b; Burstyn et al.,
2010; James et al., 2010; Kalkbrenner et al., 2012; Meguid et al.,
2010; Roza et al., 2010; Shelton et al., 2010; Dodds et al., 2011;
Lee et al., 2012; Parner et al., 2012; Rai et al., 2012; Sandin et al.,
2012; Schmidt et al., 2012), results remain largely mixed and are
strongest for advanced maternal age.
Variable distributions of genetic polymorphisms associated
with the inflammatory response may be related to the risk
of ASD development in the presence of a intrauterine infec-
tion/inflammation (Nelson et al., 2005; Wu et al., 2009). Inherited
cytokine or chemokine polymorphisms influence the risk for pre
and perinatal brain damage contributing to cognitive impairment
(Harding et al., 2005), intraventricular hemorrhage (Adcock et al.,
2003; Heep et al., 2005) and cerebral palsy (Nelson et al., 2005;
Gibson et al., 2006; Wu et al., 2009). The first comprehen-
sive gene-expression analysis of the CNS in patients with ASD
(Voineagu et al., 2011), observed that immune genes and glial
markers were over-expressed, supporting the findings of immune
dysregulation in ASD. An epidemiological study recently observed
that while siblings of children with ASD had fewer prenatal or
perinatal complications than their affected siblings, such com-
plications were significant higher than control subjects (Glasson
et al., 2004). Suggesting that siblings of children with ASD have
reacted differently to similar environmental stimuli, perhaps due
to altered gene-environment interactions.
CONCLUSIONS
We have summarized the extant research that preterm infants
may be at increased risk of developing ASD, and how maternal
infection/inflammation along with modifying gene-environment
interactions may be a predisposing factor. While the underlying
mechanism is not understood, the association between mater-
nal infection/inflammation provides a promising field of enquiry.
There is an evident lack of large-scale prospective studies: (i)
to ascertain the true incidence of ASD among children born
preterm and (ii) To characterize the risk factors preterm infants
who develop ASD, specifically maternal infection/inflammation.
Such future studies could also have preventative implications,
where treatment to minimize such risk factors could be bet-
ter implemented to minimize the risk of children born preterm
developing ASD.
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